AzTrials
AzTrials

DysphoniaNCT05479643

A Personalized Voice Restoration Device for Patients With Laryngectomy

A study testing Surface Electromyography in people with Dysphonia and Aphonia, run by Weill Medical College of Cornell University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The investigators will conduct a pilot experiment for a novel and personalized method for voice restoration using machine learning applied to surface EMG (sEMG) signal from articulatory muscles of the face and the neck allowing recognition of silent speech. Read more about this study

Who is it for?
Ages 18 to 110 yearsHealthy volunteers can take part
Conditions the study is for
Dysphonia, Aphonia
What is being tested?
Surface Electromyography
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteUnited States
Study dates
1 Dec 2027to Dec 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 110 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Group A: Healthy Volunteers
  • Adult subjects, 18 or older
  • Without any voice impairments
  • Group B: Subjects with Aphonia or Dysphonia
  • Adult subjects, 18 or older
  • Documentation of severe dysphonia and/or aphonia, or a GRBAS score > 0 (GRBAS is a scale that can be used to assess voice quality of subjects who do not have a recorded history of dysphonia or aphonia. The GRBAS scale evaluates for grade, roughness, breathiness, asthenia, and strain).

Who cannot join

  • Group A: Healthy Volunteers
  • 1. Voice impairment
  • Group B: Subjects with Aphonia or Dysphonia
  • 1. Subjects whose face muscles are entirely paralyzed

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Anaïs Rameau, MD contact

646-962-7464

anr2783@med.cornell.edu

United States1 site
  • Weill Cornell Medicine

    New York, New York, 10022

    Anaïs Rameau, MD, 646-962-7464, anr2783@med.cornell.edu

    Anaïs Rameau, MD

Other trials in United States

About this study

Official title: A Pilot Study for a Novel and Personalized Voice Restoration Device for Patients With Laryngectomy

The investigators will conduct a pilot experiment for a novel and personalized method for voice restoration using machine learning applied to surface EMG (sEMG) signal from articulatory muscles of the face and the neck allowing recognition of silent speech. The investigators predict that the use novel personalized method for voice restoration will be feasible and successful for patients.

Read the detailed description

This is a prospective pilot study evaluating the feasibility of a personalized voice restoration device and patients' experience with it. Study participation will include a one-time visit where subjects will read passages and phrases. Acoustic and signal data will be captured. Machine learning will be applied to the data to classify words. Subjects will also participate in a qualitative interview about their experience with voice restoration devices.

Conditions
Dysphonia, Aphonia
Being tested
Surface Electromyography
Medical subject headings
Dysphonia, Aphonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Surface ElectromyographyDevice

    Surface ElectroMyoGraphy (SEMG) is a non-invasive technique for measuring muscle electrical activity that occurs during muscle contraction and relaxation cycles. Electrodes will be attached with a AgCl gel to muscles used for articulation.

Study groups in NCT05479643
Study groupRoleWhat they receive
Patients with Aphonia or DysphoniaExperimentalParticipants with Aphonia or Dysphonia will be asked to recite phrases with sEMG attached to articulatory muscles.
Receives: Device: Surface Electromyography
Healthy VolunteersPlacebo comparatorHealthy Volunteer will be asked to recite phrases with sEMG attached to articulatory muscles.
Receives: Device: Surface Electromyography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Words and Numbers Correctly Identified

    Accuracy of sEMG signal will be determined by subjects reciting common phrases. Subjects will recite the "Rainbow Passage" 10 times. Subjects will be asked to count from 1-10 once. Subjects will recite the alphabet once.

    Measured: "During Procedure/use of Surface ElectroMyoGraphy"

  2. Subject experience with voice restoration devices: Qualitative

    Subject will be asked to complete a semi-structured interview about their experience with voice restoration devices. Categories of response include voice/communication history, experience with previous voice restoration devices, experience with our device, and suggestions for improvement.

    Measured: 10 minutes after the time of intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2022
  2. Study start1 Dec 2027 (estimated)
  3. Primary completion1 Dec 2029 (estimated)
  4. Study completionDec 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05479643
Sponsor's protocol ID
22-03024627
Status last verified
Jun 2026
First submitted
25 Jul 2022
Last updated
16 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Surface Electromyography in people with Dysphonia and Aphonia, run by Weill Medical College of Cornell University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anaïs Rameau, MD (646-962-7464, anr2783@med.cornell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Words and Numbers Correctly Identified (time frame: "During Procedure/use of Surface ElectroMyoGraphy"). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in